Mirae Asset Global Investments
ADVM

Mirae Asset Global Investments’s Adverum Biotechnologies ADVM Stock Holding History

Mirae Asset Global Investments’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-38,762
Closed -$508K – 2397
2022
Q1 		$508K Sell
38,762
-3,939
-9% -$57.6K ﹤0.01% 1449
2021
Q4 		$752K Buy
42,701
+15,806
+59% +$316K ﹤0.01% 1372
2021
Q3 		$584K Buy
26,895
+5,054
+23% +$129K ﹤0.01% 1458
2021
Q2 		$765K Buy
21,841
+2,494
+13% +$134K ﹤0.01% 1347
2021
Q1 		$1.91M Buy
19,347
+8,795
+83% +$1.06M 0.01% 967
2020
Q4 		$1.14M Buy
10,552
+3,819
+57% +$472K ﹤0.01% 1101
2020
Q3 		$694K Buy
6,733
+2,124
+46% +$318K ﹤0.01% 1088
2020
Q2 		$962K Buy
4,609
+2,440
+112% +$432K 0.01% 921
2020
Q1 		$212K Buy
2,169
+236
+12% +$27.5K ﹤0.01% 1298
2019
Q4 		$222K Buy
1,933
+230
+14% +$20.3K ﹤0.01% 1415
2019
Q3 		$93K Buy
+1,703
New +$192K ﹤0.01% 1413

Other funds holding ADVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Mirae Asset Global Investments's ADVM Position: Q2 2022 in Review

Mirae Asset Global Investments sold out of Adverum Biotechnologies (ADVM) in Q2 2022, closing a stake of 38,762 shares — an estimated $508K sold.

Mirae Asset Global Investments first reported a position in ADVM in Q3 2019 and held it in 11 quarters. The position peaked at $1.91M in Q1 2021. 77 funds tracked by Wall St. Rank hold ADVM as of Q2 2022.

  • Mirae Asset Global Investments reported no remaining Adverum Biotechnologies position as of Q2 2022 after selling out during the quarter.
  • Mirae Asset Global Investments sold 38,762 Adverum Biotechnologies shares in Q2 2022, an estimated $508K.
  • Mirae Asset Global Investments first reported a position in Adverum Biotechnologies in Q3 2019 and held it in 11 quarters.
  • Mirae Asset Global Investments's Adverum Biotechnologies position peaked at $1.91M in Q1 2021.
  • 77 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q2 2022.

Based on Mirae Asset Global Investments's 13F filing for Q2 2022, filed 26 Jul 2022.